ASMB Assembly Biosciences, Inc.

NASDAQ
$23.67

Assembly Biosciences, Inc. (ASMB) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.44 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -21.3% since its last earnings release on August 13, 2026.

Assembly Biosciences Beat Consensus Estimates
Thursday, August 13, 2026 · 4:00 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:00 PM ET
Earnings Whisper
-
vs ($0.44)
Rev est $8.2M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $30.34

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Assembly Biosciences, Inc.

Assembly Biosciences Inc, formerly Ventrus Biosciences Inc, is a pharmaceutical company. The Company is engaged in the late-stage clinical development of gastrointestinal products in areas of unmet need, anal fissures, and fecal incontinence.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.